This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Feb;44(2):179-182.

doi: 10.1007/s00259-016-3548-5.

Radioiodine - the success story of Nuclear Medicine : 75th Anniversary of the first use of Iodine-131 in humans

V Ralph McCready¹

Affiliations

PMID: 27761621
DOI: 10.1007/s00259-016-3548-5

Editorial

Radioiodine - the success story of Nuclear Medicine : 75th Anniversary of the first use of Iodine-131 in humans

V Ralph McCready. Eur J Nucl Med Mol Imaging. 2017 Feb.

. 2017 Feb;44(2):179-182.

doi: 10.1007/s00259-016-3548-5.

Author

V Ralph McCready¹

Affiliation

¹ Department Nuclear Medicine Royal Sussex County Hospital East Sussex UK, Brighton, UK. Ralph.McCready@BSUH.nhs.uk.

PMID: 27761621
DOI: 10.1007/s00259-016-3548-5

No abstract available

PubMed Disclaimer

Similar articles

Evaluation of toxicological hazards from medical radioiodine administration.
Van Dyke M, Punja M, Hall MJ, Kazzi Z. Van Dyke M, et al. J Med Toxicol. 2015 Mar;11(1):96-101. doi: 10.1007/s13181-014-0412-5. J Med Toxicol. 2015. PMID: 25008160 Free PMC article. Review. No abstract available.
Administering radioiodine treatment; alternatives to nuclear medicine prescribing.
Singh R, Aitken M. Singh R, et al. Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):426. doi: 10.1007/s00259-006-0278-0. Eur J Nucl Med Mol Imaging. 2007. PMID: 17109168 No abstract available.
Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
Kalinyak JE, McDougall IR. Kalinyak JE, et al. Nucl Med Commun. 2004 Sep;25(9):883-9. doi: 10.1097/00006231-200409000-00004. Nucl Med Commun. 2004. PMID: 15319592 Review. No abstract available.
Administering radioiodine treatment; alternative to nuclear medicine prescribing.
Salvatori M, Mansi L. Salvatori M, et al. Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1512-3. doi: 10.1007/s00259-007-0470-x. Eur J Nucl Med Mol Imaging. 2007. PMID: 17503038 No abstract available.
Thyroid blocking policy--revisited.
Solanki KK, Bomanji JB, Waddington WA, Ell PJ; UK Administration of Radioactive Substances Advisory Committee. Solanki KK, et al. Nucl Med Commun. 2004 Nov;25(11):1071-6. doi: 10.1097/00006231-200411000-00001. Nucl Med Commun. 2004. PMID: 15577583 No abstract available.

See all similar articles

Cited by

Cross-Isotopic Bioorthogonal Tools as Molecular Twins for Radiotheranostic Applications.
Rosecker V, Denk C, Maurer M, Wilkovitsch M, Mairinger S, Wanek T, Mikula H. Rosecker V, et al. Chembiochem. 2019 Jun 14;20(12):1530-1535. doi: 10.1002/cbic.201900042. Epub 2019 May 8. Chembiochem. 2019. PMID: 30742739 Free PMC article.
PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives.
El Fakiri M, Geis NM, Ayada N, Eder M, Eder AC. El Fakiri M, et al. Cancers (Basel). 2021 Aug 5;13(16):3967. doi: 10.3390/cancers13163967. Cancers (Basel). 2021. PMID: 34439121 Free PMC article. Review.
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of ¹³¹I during radioiodine therapy of Graves' disease.
Happel C, Kranert WT, Gröner D, Baumgarten J, Halstenberg J, Bockisch B, Sabet A, Grünwald F. Happel C, et al. Endocrine. 2021 Jul;73(1):125-130. doi: 10.1007/s12020-020-02593-x. Epub 2021 Jan 13. Endocrine. 2021. PMID: 33439464 Free PMC article.
New Opportunities and Old Challenges in the Clinical translation of Nanotheranostics.
Gawne PJ, Ferreira M, Papaluca M, Grimm J, Decuzzi P. Gawne PJ, et al. Nat Rev Mater. 2023 Dec;8(12):783-798. doi: 10.1038/s41578-023-00581-x. Epub 2023 Jul 26. Nat Rev Mater. 2023. PMID: 39022623 Free PMC article.
Personalized Diagnosis in Differentiated Thyroid Cancers by Molecular and Functional Imaging Biomarkers: Present and Future.
Teodoriu L, Leustean L, Ungureanu MC, Bilha S, Grierosu I, Matei M, Preda C, Stefanescu C. Teodoriu L, et al. Diagnostics (Basel). 2022 Apr 10;12(4):944. doi: 10.3390/diagnostics12040944. Diagnostics (Basel). 2022. PMID: 35453992 Free PMC article. Review.

See all "Cited by" articles

References

1. Thyroid. 2016 Oct;26(10 ):1343-1421 - PubMed
1. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59 - PubMed
1. Cancer. 2011 Oct 1;117(19):4439-46 - PubMed
1. J Clin Endocrinol Metab. 2013 May;98 (5):1819-25 - PubMed
1. N Engl J Med. 2012 May 3;366(18):1674-85 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information